Here's a deep dive into the nature and purposes of mission and vision statements, and why taking the time to get them right ...

When the leader becomes the primary doer or the ultimate reviewer, they inadvertently cap the organization’s potential at the limit of their own bandwidth. So as a result, growth grinds to a halt and ...

Maritime conferences across Southeast Asia and China this fall suggests a subtle shift in how regional governments approach ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

The NIS2 Directive marks a significant evolution in the European Union’s approach to cybersecurity, expanding both the scope of regulated entities ...

The musculoskeletal environment is at an important inflection point with technology developing at a faster pace, procedures becoming more minimally invasive and broader focuses on patient wellbeing, ...

Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...

Panelists share how they tailor therapy based on patient characteristics, symptoms, and clinical findings.

Travere Therapeutics' market cap has more than doubled in six months, reflecting confidence in FILSPARI's role in treating ...

The amount of separations is beyond Kupor’s previously shared target of reducing the federal workforce by 300,000 this year.

Comptroller of the Currency Jonathan Gould said in an exclusive interview with American Banker Monday that regulators must ...

Nuvectis Pharma, Inc. (NASDAQ: NVCT, the “Company”), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of ...